Liposome drug delivery system for murine neuroblastoma

Journal of Pediatric Surgery

Volumn 33, Issue 10, 1998, Pages 1521-1525

  Nagae, Itsuro ^a   Koyanagi, Yasuhisa ^a   Ito, Shinichi ^a   Tanabe, Yoshihide ^a   Unezaki, Sakae ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Liposomes; Neuroblastoma; Polyethyleneglycol

Indexed keywords

DOXORUBICIN; LIPOSOME; MACROGOL;

ADOLESCENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER TRANSPLANTATION; CARDIOTOXICITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0031784691     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(98)90489-4     Document Type: Article

References (16)

1. Mayhen EG, Lasic D, Babbar S, et al: Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int J Cacer 51:302-309, 1992
2. Olson F, Hunt CA, Szoka F, et al: Preparation of liposomes of defined size distribution by extrudition through polycarbonate membranes. Biochim Biophys Acta 557:9-23, 1979
3. Mayer LD, Bally MB, Cullis PR: Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 857:123-126, 1986
4. Hiraishi K, Suzuki K, Hakomori S, et al: Ley antigen expression is correlated with apoptosis. Glycobiology 3:381-390, 1993
5. Papahadjopoulos D, Poste G, Vail W, et al: Use of lipid vesicles as carriers to introduse actinomycin D into resistant tumor cells. Cancer Res 36:2988-2994, 1976
6. Bimanesh S, Rupak R, Pratima S, et al: Effect of liposomal encapsulation of cisplatinum diamminodichloride in the treatment of Ehrlich ascites carcinoma. Oncology 40:372-376, 1983
7. Forssen E, Tokes Z: Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes. Cancer Res 43:546-550, 1983
8. Kumai K, Takahashi T, et al: Targeted cancer chemotherapy using liposomesas a drug carrier. J Jpn Soc Clin Surg 43:1755-1764, 1988
9. Yaguchi T, Yamauchi M, Takagi H, et al: Targeting therapy of gastrointestinal cancers with sulfatide-inserted liposomes entrapping adriamycin. J Jpn Soc Clin Surg 47:1369-1372, 1989
10. Tanifuji K, Suzuki K, et al: Experimental study on local administration of liposome inclusion adriamycin. J Tokyo Med Coll 51:242-253, 1993
11. Yagyu M, Ito S, Nagae I: Experimental hyperthermochemotheraphy for neuroblastoma. J Tokyo Med Coll 52:424-437, 1994
12. Iga K, Hamaguchi M, Igari Y, et al: Heart-specific drug release of large unilamellar vesicle as hyperthermia-mediated targeting delivery. Int J Pharmacol 57:241-251, 1989
13. Klibanov AL, Maruyama K, Beckerleg AM, et al: Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1062:142-148, 1991
14. Maruyama K, Unezaki S, Takahashi N, et al: Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta 1149:209-216, 1993
15. Unezaki S, Maruyama K, Ishida O, et al: Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes. J Drug Target 1:287-292, 1993
16. Unezaki S, Maruyama K, Nagae I, et al: Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int J Pharmacol 144:11-17, 1996